A Phase I, Single-Dose, Open-Label, 5-Treatment, Crossover, Pharmacokinetic Study of Comparative Bioavailability of Epinephrine Nasal Spray and EpiPen® in Healthy Adults with Seasonal Allergies
Phase of Trial: Phase I
Latest Information Update: 14 Jun 2018
At a glance
- Drugs Epinephrine (Primary) ; Epinephrine
- Indications Anaphylaxis
- Focus Pharmacokinetics; Proof of concept
- 14 Jun 2018 Results presented in an INSYS Therapeutics media release.
- 12 Dec 2017 New trial record
- 07 Dec 2017 According to a company media release, the first patient has been enrolled in this trial. INSYS expects enrollment in the study to be complete in the first quarter of 2018, with initial results for all enrolled patients available by February.